Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01619995 · ClinicalTrials.gov registry record
Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder
A clinical trial of Urge Urinary Incontinence, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT01619995: Completed study of Urge Urinary Incontinence, sponsored by University of Pittsburgh.
NCT01619995 is a study of Urge Urinary Incontinence that has completed, run by University of Pittsburgh. The registered enrollment target is 43 participants, below the 182-participant average among 4 other Urge Urinary Incontinence trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01619995, a study of Urge Urinary Incontinence, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to evaluate the applicability of non-invasive optical imaging for the measurement of brain function during investigation of the lower urinary tract.
Conditions Studied
Study Locations (1)
Pennsylvania
- Geriatric Continence Research Unit, NE547 Montefiore UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-07 |
What the finished NCT01619995 record still lists
NCT01619995 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 182-participant average among 4 other Urge Urinary Incontinence trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Urge Urinary Incontinence appearing as the primary indexed condition, and to 0 interventions.
NCT01619995 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01619995 about?
NCT01619995 is a clinical study titled "Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder". The goal of this project is to evaluate the applicability of non-invasive optical imaging for the measurement of brain function during investigation of the lower urinary tract.
What is the current status of trial NCT01619995?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2011-08. Estimated completion is 2013-07.
What conditions does trial NCT01619995 study?
This clinical trial studies the following conditions: Urge Urinary Incontinence.
Who is sponsoring clinical trial NCT01619995?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01619995 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urge Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
RECRUITING · NA
-
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
RECRUITING · NA
-
Anticholinergic vs. Botox Comparison Study
COMPLETED · Phase 3
-
Lessening Incontinence by Learning Yoga
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia